Pharmacogenetics

Research Frontiers in NAT2 Acetylator Status in Tuberculosis Drug Efficacy

Study of N-acetyltransferase 2 phenotypes and their impact on tuberculosis treatment outcomes, particularly with rifampicin and isoniazid combinations.

All Pharmacogenetics PhD categories